269 related articles for article (PubMed ID: 22592344)
1. [Bacterial conjunctivitis--diagnosis and therapy update].
Messmer EM
Klin Monbl Augenheilkd; 2012 May; 229(5):529-33. PubMed ID: 22592344
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients.
Bremond-Gignac D; Mariani-Kurkdjian P; Beresniak A; El Fekih L; Bhagat Y; Pouliquen P; Delval L; Goldschmidt P; Bingen E; Cochereau I
Pediatr Infect Dis J; 2010 Mar; 29(3):222-6. PubMed ID: 19935122
[TBL] [Abstract][Full Text] [Related]
3. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
Abelson MB; Heller W; Shapiro AM; Si E; Hsu P; Bowman LM;
Am J Ophthalmol; 2008 Jun; 145(6):959-65. PubMed ID: 18374301
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy assessment of azithromycin 1.5% eye drops versus tobramycin 0.3% on clinical signs of purulent bacterial conjunctivitis].
Robert PY; Bourcier T; Meddeb-Ouertani A; Khairallah M; Zaghloul K; Amraoui A; Bhagat Y; Pop M; Cochereau I
J Fr Ophtalmol; 2010 Apr; 33(4):241-8. PubMed ID: 20223555
[TBL] [Abstract][Full Text] [Related]
5. Acute infective conjunctivitis: evidence review and management advice for New Zealand practitioners.
Oliver GF; Wilson GA; Everts RJ
N Z Med J; 2009 Jul; 122(1298):69-75. PubMed ID: 19680306
[TBL] [Abstract][Full Text] [Related]
6. The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.
Benitez-Del-Castillo J; Verboven Y; Stroman D; Kodjikian L
Clin Drug Investig; 2011; 31(8):543-557. PubMed ID: 21604820
[TBL] [Abstract][Full Text] [Related]
7. Besifloxacin: a topical fluoroquinolone for the treatment of bacterial conjunctivitis.
Chang MH; Fung HB
Clin Ther; 2010 Mar; 32(3):454-71. PubMed ID: 20399984
[TBL] [Abstract][Full Text] [Related]
8. Limitations of current antibiotics for the treatment of bacterial conjunctivitis.
Karpecki P; Paterno MR; Comstock TL
Optom Vis Sci; 2010 Nov; 87(11):908-19. PubMed ID: 20838353
[TBL] [Abstract][Full Text] [Related]
9. Bacterial Conjunctivitis in Childhood: Etiology, Clinical Manifestations, Diagnosis, and Management.
Leung AKC; Hon KL; Wong AHC; Wong AS
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):120-127. PubMed ID: 29380707
[TBL] [Abstract][Full Text] [Related]
10. Besifloxacin ophthalmic suspension, 0.6%: a novel topical fluoroquinolone for bacterial conjunctivitis.
O'Brien TP
Adv Ther; 2012 Jun; 29(6):473-90. PubMed ID: 22729919
[TBL] [Abstract][Full Text] [Related]
11. Acute bacterial conjunctivitis.
Høvding G
Acta Ophthalmol; 2008 Feb; 86(1):5-17. PubMed ID: 17970823
[TBL] [Abstract][Full Text] [Related]
12. Microbiological etiology and susceptibility of bacterial conjunctivitis isolates from clinical trials with ophthalmic, twice-daily besifloxacin.
Haas W; Gearinger LS; Hesje CK; Sanfilippo CM; Morris TW
Adv Ther; 2012 May; 29(5):442-55. PubMed ID: 22644963
[TBL] [Abstract][Full Text] [Related]
13. [Gonococcal conjunctivitis in a young woman].
Biance-Valero E; Quiniou PY; Valero B; Navarrot JC; Soullié B
J Fr Ophtalmol; 2013 Dec; 36(10):e201-6. PubMed ID: 24210280
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of effectiveness and tolerance of treatment with azithromycin 1.5% eye drops in bacterial conjunctivitis].
Ambroziak AM; Szaflik JP; Hapunik A
Klin Oczna; 2009; 111(1-3):46-9. PubMed ID: 19517846
[TBL] [Abstract][Full Text] [Related]
15. Acute bacterial conjunctivitis - antibiotic susceptibility and resistance to commercially available topical antibiotics in Nepal.
Shrestha SP; Khadka J; Pokhrel AK; Sathian B
Nepal J Ophthalmol; 2016 Jan; 8(15):23-35. PubMed ID: 28242882
[TBL] [Abstract][Full Text] [Related]
16. Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.
Gallenga PE; Lobefalo L; Colangelo L; Della Loggia G; Orzalesi N; Velati P; Bujtar E; Ponte F; Damiani S; Bucci MG; Bonini S; Curatola MR; Palma LA; Bonomi L; Tomazzoli Gerosa L; Pagliarusco A; Milan E; Jauch A
Ophthalmologica; 1999; 213(4):250-7. PubMed ID: 10420109
[TBL] [Abstract][Full Text] [Related]
17. Besifloxacin ophthalmic suspension for bacterial conjunctivitis.
Nafziger AN; Bertino JS
Drugs Today (Barc); 2009 Aug; 45(8):577-88. PubMed ID: 19927224
[TBL] [Abstract][Full Text] [Related]
18. Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis.
Denis F; Chaumeil C; Goldschmidt P; Delval L; Pouliquen P; Cochereau I; Chainier D; De Barbeyrac B
Eur J Ophthalmol; 2008; 18(6):858-68. PubMed ID: 18988154
[TBL] [Abstract][Full Text] [Related]
19. Alcaligenes xylosoxidans conjunctivitis.
Rush R; Friedlander M
Cornea; 2007 Aug; 26(7):868-9. PubMed ID: 17667625
[TBL] [Abstract][Full Text] [Related]
20. The giant fornix syndrome: an unrecognized cause of chronic, relapsing, grossly purulent conjunctivitis.
Rose GE
Ophthalmology; 2004 Aug; 111(8):1539-45. PubMed ID: 15288985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
